0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Peptide Sequencing Reagents Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-6X17106
Home | Market Reports | Science| Biological Sciences
Global Peptide Sequencing Reagents Market Research Report 2024
BUY CHAPTERS

Global Peptide Sequencing Reagents Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-6X17106
Report
November 2025
Pages:138
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Peptide Sequencing Reagents Market

The global Peptide Sequencing Reagents market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Peptide sequencing reagents are kits used to analyze peptide sequences in protein samples. In protein research, peptide sequencing is an important technology that can determine the amino acid sequence of peptide segments in protein samples, thereby helping researchers understand the structure and function of proteins. Peptide sequencing kits usually include various chemical reagents and consumables, used For extraction, purification and analysis of peptides.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Peptide Sequencing Reagents leading manufacturers including Creative Proteomics, Biognosys, Agilent Technologies, Rapid Novor, Alta Bioscience, MtoZ Biolabs, Proteome Factory, New England Biolabs, etc., dominate supply; the top five capture approximately % of global revenue, with Creative Proteomics leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Peptide Sequencing Reagents market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Peptide Sequencing Reagents Market Report

Report Metric Details
Report Name Peptide Sequencing Reagents Market
Segment by Type
  • Reagents
  • Reagent Test Kit
Segment by Application
  • Hospital
  • Scientific Research Institution
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Creative Proteomics, Biognosys, Agilent Technologies, Rapid Novor, Alta Bioscience, MtoZ Biolabs, Proteome Factory, New England Biolabs
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Peptide Sequencing Reagents study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Peptide Sequencing Reagents Market report?

Ans: The main players in the Peptide Sequencing Reagents Market are Creative Proteomics, Biognosys, Agilent Technologies, Rapid Novor, Alta Bioscience, MtoZ Biolabs, Proteome Factory, New England Biolabs

What are the Application segmentation covered in the Peptide Sequencing Reagents Market report?

Ans: The Applications covered in the Peptide Sequencing Reagents Market report are Hospital, Scientific Research Institution

What are the Type segmentation covered in the Peptide Sequencing Reagents Market report?

Ans: The Types covered in the Peptide Sequencing Reagents Market report are Reagents, Reagent Test Kit

1 Study Coverage
1.1 Introduction to Peptide Sequencing Reagents: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Peptide Sequencing Reagents Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Reagents
1.2.3 Reagent Test Kit
1.3 Market Segmentation by Application
1.3.1 Global Peptide Sequencing Reagents Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Scientific Research Institution
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Peptide Sequencing Reagents Revenue Estimates and Forecasts 2020-2031
2.2 Global Peptide Sequencing Reagents Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Peptide Sequencing Reagents Sales Estimates and Forecasts 2020-2031
2.4 Global Peptide Sequencing Reagents Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Peptide Sequencing Reagents Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Peptide Sequencing Reagents Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Reagents Market Size by Manufacturers
3.5.2 Reagent Test Kit Market Size by Manufacturers
3.6 Global Peptide Sequencing Reagents Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Peptide Sequencing Reagents Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Peptide Sequencing Reagents Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Peptide Sequencing Reagents Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Peptide Sequencing Reagents Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Peptide Sequencing Reagents Sales and Revenue by Type (2020-2031)
6.4 North America Peptide Sequencing Reagents Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Peptide Sequencing Reagents Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Peptide Sequencing Reagents Sales and Revenue by Type (2020-2031)
7.4 Europe Peptide Sequencing Reagents Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Peptide Sequencing Reagents Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Peptide Sequencing Reagents Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Peptide Sequencing Reagents Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Peptide Sequencing Reagents Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Peptide Sequencing Reagents Sales and Revenue by Type (2020-2031)
9.4 Central and South America Peptide Sequencing Reagents Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Peptide Sequencing Reagents Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Peptide Sequencing Reagents Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Peptide Sequencing Reagents Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Peptide Sequencing Reagents Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Creative Proteomics
11.1.1 Creative Proteomics Corporation Information
11.1.2 Creative Proteomics Business Overview
11.1.3 Creative Proteomics Peptide Sequencing Reagents Product Models, Descriptions and Specifications
11.1.4 Creative Proteomics Peptide Sequencing Reagents Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Creative Proteomics Peptide Sequencing Reagents Sales by Product in 2024
11.1.6 Creative Proteomics Peptide Sequencing Reagents Sales by Application in 2024
11.1.7 Creative Proteomics Peptide Sequencing Reagents Sales by Geographic Area in 2024
11.1.8 Creative Proteomics Peptide Sequencing Reagents SWOT Analysis
11.1.9 Creative Proteomics Recent Developments
11.2 Biognosys
11.2.1 Biognosys Corporation Information
11.2.2 Biognosys Business Overview
11.2.3 Biognosys Peptide Sequencing Reagents Product Models, Descriptions and Specifications
11.2.4 Biognosys Peptide Sequencing Reagents Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Biognosys Peptide Sequencing Reagents Sales by Product in 2024
11.2.6 Biognosys Peptide Sequencing Reagents Sales by Application in 2024
11.2.7 Biognosys Peptide Sequencing Reagents Sales by Geographic Area in 2024
11.2.8 Biognosys Peptide Sequencing Reagents SWOT Analysis
11.2.9 Biognosys Recent Developments
11.3 Agilent Technologies
11.3.1 Agilent Technologies Corporation Information
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Peptide Sequencing Reagents Product Models, Descriptions and Specifications
11.3.4 Agilent Technologies Peptide Sequencing Reagents Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Agilent Technologies Peptide Sequencing Reagents Sales by Product in 2024
11.3.6 Agilent Technologies Peptide Sequencing Reagents Sales by Application in 2024
11.3.7 Agilent Technologies Peptide Sequencing Reagents Sales by Geographic Area in 2024
11.3.8 Agilent Technologies Peptide Sequencing Reagents SWOT Analysis
11.3.9 Agilent Technologies Recent Developments
11.4 Rapid Novor
11.4.1 Rapid Novor Corporation Information
11.4.2 Rapid Novor Business Overview
11.4.3 Rapid Novor Peptide Sequencing Reagents Product Models, Descriptions and Specifications
11.4.4 Rapid Novor Peptide Sequencing Reagents Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Rapid Novor Peptide Sequencing Reagents Sales by Product in 2024
11.4.6 Rapid Novor Peptide Sequencing Reagents Sales by Application in 2024
11.4.7 Rapid Novor Peptide Sequencing Reagents Sales by Geographic Area in 2024
11.4.8 Rapid Novor Peptide Sequencing Reagents SWOT Analysis
11.4.9 Rapid Novor Recent Developments
11.5 Alta Bioscience
11.5.1 Alta Bioscience Corporation Information
11.5.2 Alta Bioscience Business Overview
11.5.3 Alta Bioscience Peptide Sequencing Reagents Product Models, Descriptions and Specifications
11.5.4 Alta Bioscience Peptide Sequencing Reagents Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Alta Bioscience Peptide Sequencing Reagents Sales by Product in 2024
11.5.6 Alta Bioscience Peptide Sequencing Reagents Sales by Application in 2024
11.5.7 Alta Bioscience Peptide Sequencing Reagents Sales by Geographic Area in 2024
11.5.8 Alta Bioscience Peptide Sequencing Reagents SWOT Analysis
11.5.9 Alta Bioscience Recent Developments
11.6 MtoZ Biolabs
11.6.1 MtoZ Biolabs Corporation Information
11.6.2 MtoZ Biolabs Business Overview
11.6.3 MtoZ Biolabs Peptide Sequencing Reagents Product Models, Descriptions and Specifications
11.6.4 MtoZ Biolabs Peptide Sequencing Reagents Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 MtoZ Biolabs Recent Developments
11.7 Proteome Factory
11.7.1 Proteome Factory Corporation Information
11.7.2 Proteome Factory Business Overview
11.7.3 Proteome Factory Peptide Sequencing Reagents Product Models, Descriptions and Specifications
11.7.4 Proteome Factory Peptide Sequencing Reagents Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Proteome Factory Recent Developments
11.8 New England Biolabs
11.8.1 New England Biolabs Corporation Information
11.8.2 New England Biolabs Business Overview
11.8.3 New England Biolabs Peptide Sequencing Reagents Product Models, Descriptions and Specifications
11.8.4 New England Biolabs Peptide Sequencing Reagents Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 New England Biolabs Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Peptide Sequencing Reagents Industry Chain
12.2 Peptide Sequencing Reagents Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Peptide Sequencing Reagents Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Peptide Sequencing Reagents Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Peptide Sequencing Reagents Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Peptide Sequencing Reagents Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Peptide Sequencing Reagents Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Peptide Sequencing Reagents Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Peptide Sequencing Reagents Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Peptide Sequencing Reagents Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Peptide Sequencing Reagents Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Peptide Sequencing Reagents Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
 Table 7. Global Peptide Sequencing Reagents Sales by Region (2020-2025) & (Units)
 Table 8. Global Peptide Sequencing Reagents Sales by Region (2026-2031) & (Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Peptide Sequencing Reagents Sales by Manufacturers (2020-2025) & (Units)
 Table 11. Global Peptide Sequencing Reagents Sales Share by Manufacturers (2020-2025)
 Table 12. Global Peptide Sequencing Reagents Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Peptide Sequencing Reagents Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Peptide Sequencing Reagents by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Sequencing Reagents as of 2024)
 Table 16. Global Peptide Sequencing Reagents Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Peptide Sequencing Reagents Average Selling Price (ASP) by Manufacturers (2020-2025) & (K US$/Unit)
 Table 18. Key Manufacturers Peptide Sequencing Reagents Manufacturing Base and Headquarters
 Table 19. Global Peptide Sequencing Reagents Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Peptide Sequencing Reagents Sales by Type (2020-2025) & (Units)
 Table 23. Global Peptide Sequencing Reagents Sales by Type (2026-2031) & (Units)
 Table 24. Global Peptide Sequencing Reagents Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Peptide Sequencing Reagents Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Peptide Sequencing Reagents ASP by Type (2020-2031) & (K US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Peptide Sequencing Reagents Sales by Application (2020-2025) & (Units)
 Table 29. Global Peptide Sequencing Reagents Sales by Application (2026-2031) & (Units)
 Table 30. Peptide Sequencing Reagents High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Peptide Sequencing Reagents Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Peptide Sequencing Reagents Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Peptide Sequencing Reagents ASP by Application (2020-2031) & (K US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Peptide Sequencing Reagents Growth Accelerators and Market Barriers
 Table 37. North America Peptide Sequencing Reagents Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Peptide Sequencing Reagents Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Peptide Sequencing Reagents Growth Accelerators and Market Barriers
 Table 40. Europe Peptide Sequencing Reagents Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Peptide Sequencing Reagents Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Peptide Sequencing Reagents Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Peptide Sequencing Reagents Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Peptide Sequencing Reagents Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Peptide Sequencing Reagents Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Peptide Sequencing Reagents Investment Opportunities and Key Challenges
 Table 47. Central and South America Peptide Sequencing Reagents Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Peptide Sequencing Reagents Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Peptide Sequencing Reagents Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Creative Proteomics Corporation Information
 Table 51. Creative Proteomics Description and Major Businesses
 Table 52. Creative Proteomics Product Models, Descriptions and Specifications
 Table 53. Creative Proteomics Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 54. Creative Proteomics Sales Value Proportion by Product in 2024
 Table 55. Creative Proteomics Sales Value Proportion by Application in 2024
 Table 56. Creative Proteomics Sales Value Proportion by Geographic Area in 2024
 Table 57. Creative Proteomics Peptide Sequencing Reagents SWOT Analysis
 Table 58. Creative Proteomics Recent Developments
 Table 59. Biognosys Corporation Information
 Table 60. Biognosys Description and Major Businesses
 Table 61. Biognosys Product Models, Descriptions and Specifications
 Table 62. Biognosys Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 63. Biognosys Sales Value Proportion by Product in 2024
 Table 64. Biognosys Sales Value Proportion by Application in 2024
 Table 65. Biognosys Sales Value Proportion by Geographic Area in 2024
 Table 66. Biognosys Peptide Sequencing Reagents SWOT Analysis
 Table 67. Biognosys Recent Developments
 Table 68. Agilent Technologies Corporation Information
 Table 69. Agilent Technologies Description and Major Businesses
 Table 70. Agilent Technologies Product Models, Descriptions and Specifications
 Table 71. Agilent Technologies Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 72. Agilent Technologies Sales Value Proportion by Product in 2024
 Table 73. Agilent Technologies Sales Value Proportion by Application in 2024
 Table 74. Agilent Technologies Sales Value Proportion by Geographic Area in 2024
 Table 75. Agilent Technologies Peptide Sequencing Reagents SWOT Analysis
 Table 76. Agilent Technologies Recent Developments
 Table 77. Rapid Novor Corporation Information
 Table 78. Rapid Novor Description and Major Businesses
 Table 79. Rapid Novor Product Models, Descriptions and Specifications
 Table 80. Rapid Novor Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 81. Rapid Novor Sales Value Proportion by Product in 2024
 Table 82. Rapid Novor Sales Value Proportion by Application in 2024
 Table 83. Rapid Novor Sales Value Proportion by Geographic Area in 2024
 Table 84. Rapid Novor Peptide Sequencing Reagents SWOT Analysis
 Table 85. Rapid Novor Recent Developments
 Table 86. Alta Bioscience Corporation Information
 Table 87. Alta Bioscience Description and Major Businesses
 Table 88. Alta Bioscience Product Models, Descriptions and Specifications
 Table 89. Alta Bioscience Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 90. Alta Bioscience Sales Value Proportion by Product in 2024
 Table 91. Alta Bioscience Sales Value Proportion by Application in 2024
 Table 92. Alta Bioscience Sales Value Proportion by Geographic Area in 2024
 Table 93. Alta Bioscience Peptide Sequencing Reagents SWOT Analysis
 Table 94. Alta Bioscience Recent Developments
 Table 95. MtoZ Biolabs Corporation Information
 Table 96. MtoZ Biolabs Description and Major Businesses
 Table 97. MtoZ Biolabs Product Models, Descriptions and Specifications
 Table 98. MtoZ Biolabs Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 99. MtoZ Biolabs Recent Developments
 Table 100. Proteome Factory Corporation Information
 Table 101. Proteome Factory Description and Major Businesses
 Table 102. Proteome Factory Product Models, Descriptions and Specifications
 Table 103. Proteome Factory Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 104. Proteome Factory Recent Developments
 Table 105. New England Biolabs Corporation Information
 Table 106. New England Biolabs Description and Major Businesses
 Table 107. New England Biolabs Product Models, Descriptions and Specifications
 Table 108. New England Biolabs Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2020-2025)
 Table 109. New England Biolabs Recent Developments
 Table 110. Key Raw Materials Distribution
 Table 111. Raw Materials Key Suppliers
 Table 112. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 113. Milestones in Production Technology Evolution
 Table 114. Distributors List
 Table 115. Market Trends and Market Evolution
 Table 116. Market Drivers and Opportunities
 Table 117. Market Challenges, Risks, and Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources


List of Figures
 Figure 1. Peptide Sequencing Reagents Product Picture
 Figure 2. Global Peptide Sequencing Reagents Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Reagents Product Picture
 Figure 4. Reagent Test Kit Product Picture
 Figure 5. Global Peptide Sequencing Reagents Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Hospital
 Figure 7. Scientific Research Institution
 Figure 8. Peptide Sequencing Reagents Report Years Considered
 Figure 9. Global Peptide Sequencing Reagents Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 10. Global Peptide Sequencing Reagents Revenue (2020-2031) & (US$ Million)
 Figure 11. Global Peptide Sequencing Reagents Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 12. Global Peptide Sequencing Reagents Revenue Market Share by Region (2020-2031)
 Figure 13. Global Peptide Sequencing Reagents Sales (2020-2031) & (Units)
 Figure 14. Global Peptide Sequencing Reagents Sales (CAGR) by Region (2020-2031) (Units)
 Figure 15. Global Peptide Sequencing Reagents Sales Market Share by Region (2020-2031)
 Figure 16. Top 5 and Top 10 Manufacturers Peptide Sequencing Reagents Sales Volume Market Share in 2024
 Figure 17. Global Peptide Sequencing Reagents Revenue Market Share Ranking (2024)
 Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 19. Reagents Revenue Market Share by Manufacturer in 2024
 Figure 20. Reagent Test Kit Revenue Market Share by Manufacturer in 2024
 Figure 21. Global Peptide Sequencing Reagents Sales Market Share by Type (2020-2031)
 Figure 22. Global Peptide Sequencing Reagents Revenue Market Share by Type (2020-2031)
 Figure 23. Global Peptide Sequencing Reagents Sales Market Share by Application (2020-2031)
 Figure 24. Global Peptide Sequencing Reagents Revenue Market Share by Application (2020-2031)
 Figure 25. North America Peptide Sequencing Reagents Sales YoY (2020-2031) & (Units)
 Figure 26. North America Peptide Sequencing Reagents Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. North America Top 5 Manufacturers Peptide Sequencing Reagents Sales Revenue (US$ Million) in 2024
 Figure 28. North America Peptide Sequencing Reagents Sales Volume (Units) by Type (2020- 2031)
 Figure 29. North America Peptide Sequencing Reagents Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 30. North America Peptide Sequencing Reagents Sales Volume (Units) by Application (2020-2031)
 Figure 31. North America Peptide Sequencing Reagents Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 32. US Peptide Sequencing Reagents Revenue (2020-2031) & (US$ Million)
 Figure 33. Canada Peptide Sequencing Reagents Revenue (2020-2031) & (US$ Million)
 Figure 34. Mexico Peptide Sequencing Reagents Revenue (2020-2031) & (US$ Million)
 Figure 35. Europe Peptide Sequencing Reagents Sales YoY (2020-2031) & (Units)
 Figure 36. Europe Peptide Sequencing Reagents Revenue YoY (2020-2031) & (US$ Million)
 Figure 37. Europe Top 5 Manufacturers Peptide Sequencing Reagents Sales Revenue (US$ Million) in 2024
 Figure 38. Europe Peptide Sequencing Reagents Sales Volume (Units) by Type (2020-2031)
 Figure 39. Europe Peptide Sequencing Reagents Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 40. Europe Peptide Sequencing Reagents Sales Volume (Units) by Application (2020-2031)
 Figure 41. Europe Peptide Sequencing Reagents Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 42. Germany Peptide Sequencing Reagents Revenue (2020-2031) & (US$ Million)
 Figure 43. France Peptide Sequencing Reagents Revenue (2020-2031) & (US$ Million)
 Figure 44. U.K. Peptide Sequencing Reagents Revenue (2020-2031) & (US$ Million)
 Figure 45. Italy Peptide Sequencing Reagents Revenue (2020-2031) & (US$ Million)
 Figure 46. Russia Peptide Sequencing Reagents Revenue (2020-2031) & (US$ Million)
 Figure 47. Asia-Pacific Peptide Sequencing Reagents Sales YoY (2020-2031) & (Units)
 Figure 48. Asia-Pacific Peptide Sequencing Reagents Revenue YoY (2020-2031) & (US$ Million)
 Figure 49. Asia-Pacific Top 8 Manufacturers Peptide Sequencing Reagents Sales Revenue (US$ Million) in 2024
 Figure 50. Asia-Pacific Peptide Sequencing Reagents Sales Volume (Units) by Type (2020- 2031)
 Figure 51. Asia-Pacific Peptide Sequencing Reagents Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 52. Asia-Pacific Peptide Sequencing Reagents Sales Volume (Units) by Application (2020-2031)
 Figure 53. Asia-Pacific Peptide Sequencing Reagents Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 54. Indonesia Peptide Sequencing Reagents Revenue (2020-2031) & (US$ Million)
 Figure 55. Japan Peptide Sequencing Reagents Revenue (2020-2031) & (US$ Million)
 Figure 56. South Korea Peptide Sequencing Reagents Revenue (2020-2031) & (US$ Million)
 Figure 57. China Taiwan Peptide Sequencing Reagents Revenue (2020-2031) & (US$ Million)
 Figure 58. India Peptide Sequencing Reagents Revenue (2020-2031) & (US$ Million)
 Figure 59. Central and South America Peptide Sequencing Reagents Sales YoY (2020-2031) & (Units)
 Figure 60. Central and South America Peptide Sequencing Reagents Revenue YoY (2020-2031) & (US$ Million)
 Figure 61. Central and South America Top 5 Manufacturers Peptide Sequencing Reagents Sales Revenue (US$ Million) in 2024
 Figure 62. Central and South America Peptide Sequencing Reagents Sales Volume (Units) by Type (2021-2031)
 Figure 63. Central and South America Peptide Sequencing Reagents Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 64. Central and South America Peptide Sequencing Reagents Sales Volume (Units) by Application (2020-2031)
 Figure 65. Central and South America Peptide Sequencing Reagents Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 66. Brazil Peptide Sequencing Reagents Revenue (2020-2025) & (US$ Million)
 Figure 67. Argentina Peptide Sequencing Reagents Revenue (2020-2025) & (US$ Million)
 Figure 68. Middle East, and Africa Peptide Sequencing Reagents Sales YoY (2020-2031) & (Units)
 Figure 69. Middle East and Africa Peptide Sequencing Reagents Revenue YoY (2020-2031) & (US$ Million)
 Figure 70. Middle East and Africa Top 5 Manufacturers Peptide Sequencing Reagents Sales Revenue (US$ Million) in 2024
 Figure 71. Middle East and Africa Peptide Sequencing Reagents Sales Volume (Units) by Type (2021-2031)
 Figure 72. South America Peptide Sequencing Reagents Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 73. Middle East and Africa Peptide Sequencing Reagents Sales Volume (Units) by Application (2020-2031)
 Figure 74. Middle East and Africa Peptide Sequencing Reagents Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 75. GCC Countries Peptide Sequencing Reagents Revenue (2020-2025) & (US$ Million)
 Figure 76. Turkey Peptide Sequencing Reagents Revenue (2020-2025) & (US$ Million)
 Figure 77. Egypt Peptide Sequencing Reagents Revenue (2020-2025) & (US$ Million)
 Figure 78. South Africa Peptide Sequencing Reagents Revenue (2020-2025) & (US$ Million)
 Figure 79. Peptide Sequencing Reagents Industry Chain Mapping
 Figure 80. Regional Peptide Sequencing Reagents Manufacturing Base Distribution (%)
 Figure 81. Global Peptide Sequencing Reagents Production Market Share by Region (2020-2031)
 Figure 82. Peptide Sequencing Reagents Production Process
 Figure 83. Regional Peptide Sequencing Reagents Production Cost Structure
 Figure 84. Channels of Distribution (Direct Vs Distribution)
 Figure 85. Bottom-up and Top-down Approaches for This Report
 Figure 86. Data Triangulation
 Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension